Effect of insurance on mortality in an hiv-positive population in care

Journal of the American Statistical Association

Volumn 96, Issue 455, 2001, Pages 883-894

  Goldman, Dana P ^a   Bhattacharya, Jayanta ^a   McCaffrey, Daniel F ^a   Duan, Naihua ^b   Leibowitz, Arleen A ^c   Joyce, Geoffrey F ^a   Morton, Sally C ^a  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; Bivariate normal; Instrumental variable; Potential outcome; Probit; Switching regression

Indexed keywords

EID: 0442296621     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1198/016214501753208582     Document Type: Article

References (41)

1. Angrist, J. D. (1991), “Instrumental Variables Estimation of Average Treatment Effects in Econometrics and Epidemiology,” Technical Paper 115, National Bureau of Economic Research.
2. Angrist, J. D., and Evans, W. N. (1998), “Children and Their Parents’ Labor Supply: Evidence from Exogenous Variation in Family Size,” American Economic Review, 88, 450–477.
3. Angrist, J. D., and Imbens, G. W. (1994), “Identification and Estimation of Local Average Treatment Effects,” Econometrica, 62, 467–475.
4. Angrist, J. D., Imbens G., and Rubin, D. B. (1996), “Identification of Causal Effects Using Instrumental Variables,” Journal of the American Statistical Association, 91, 444–455; 468–472.
5. Bhattacharya, J., McCaffrey, D., and Goldman, D. (1999), “Estimating Probit Models with Endogenous Covariates,” unpublished mimeo, RAND Corporation.
6. Binder, D. A. (1983), “On the Variances of Asymptotically Normal Estimators From Complex Surveys,” International Statistical Review, 51, 279–292.
7. Bound, J., Jaeger, D., and Baker, R. (1995), “Problems With Instrumental Variables Estimation When the Correlation Between the Instruments and the Endogenous Explanatory Variable is Weak,” Journal of the American Statistical Association, 90, 443–450.
8. Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., Emmons, C., Senterfitt, J. W., Berk, M. L., Morton, S. C., and Shapiro, M. F. (1998), “The Care of HIV-Infected Adults in the United States,” New England Journal of Medicine, 339, 1897–1904.
9. Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., and Volberding, P. A. (1998), “Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the Internal AIDS Society-USA Panel,” Journal of the American Medical Association, 280, 78–86.
10. Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Ones, M., Facey, K., Whitacre, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., and Corey, L. (1996), “Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine,” New England Journal of Medicine, 334, 1011–1017.
11. Cox, D. R. (1958), Planning of Experiments, New York: Wiley.
12. Cutler, D. M., and Gruber, J. (1996), “The Effect of Medicaid Expansions on Pulbic Insurance, Private Insurance, and Redistribution,” The American Economic Review, 86, 378–383.
13. Doyle, A., Jefferys, R., and Kelly, J. (1998), “National ADAP Monitoring Project: Interim Technical Report,” National Alliance of State and Territorial AIDS Directors and the AIDS Treatment Data Network. Available at http://www.aidsinfonyc.org/adap.
14. Duan, N., McCaffrey, D. F., Frankel, M. R., Clair, P. St. A., Beckman, R., Keesey, J. W., Chien, C., Goldman, D. P., Smith, S. M., and Morton, S. C. (1999), “HCSUS Baseline Methods Technical Report: Weighting, Imputation and Variance Estimation,” Report MR-1060-AHCPR, RAND Corporation.
15. Evans, W. N., and Schwab, R. M. (1995), “Finishing High School and Starting College: Do Catholic Schools Make a Difference?” Quarterly Journal of Economics, 110, 941–974.
16. Evans, W. N., Farrelly, M. C., and Montgomery, E. (1999), “Do Workplace Smoking Bans Reduce Smoking?” American Economic Review, 89, 728–747.
17. Frankel, M., Shapiro, M., Duan, N., Morton, S., Berry, S., Brown, J., Burnam, A., Cohn, S., Goldman, D., McCaffrey, D., Smith, S., Clair, P. St., Tebow, J., and Bozzette, S. (1999), “National Probability Samples in Studies of Low-Prevalence Diseases. Part II: Designing and Implementing the HIV Cost and Services Utilization Study Sample,” Health Services Research, 34, 969–992.
18. Greene, W. H. (2000), Econometric Analysis, (4th ed.), Upper Saddle River, NJ: Prentice-Hall.
19. Harrison, T. R., Fauci, A. S., Hauser, S. L., and Braunwald, E. (eds.) (1997), Harrison’s Principles of Internal Medicine (14th ed.), New York: McGraw-Hill.
20. Heckman, J. J., and Honoré, B. (1990), “The Empirical Content of the Roy Model,” Econometrica, 58, 1121–1149.
21. Heckman, J. J., and Vytlacil, E. J. (1999), “Local Instrumental Variables and Latent Variable Models for Identifying and Bounding Treatment Effects,” Proceedings of the National Academy of Sciences, 96, 4730–4734.
22. Holland, P. (1986), “Statistics and Causal Inference,” Journal of the American Statistical Association, 81, 945–970.
23. Hosmer, D. W., Jr., and Lemeshow, S. (1989), “Special Topics. Assessment of Fit and Diagnostics for Polytomous Logistic Regression Model,” in Applied Logistic Regression, New York: Wiley.
24. Huber, P. J. (1967), “The Behavior of Maximum Likelihood Estimates Under Non-Standard Conditions,” Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability, 1, 221–233.
25. Imbens, G. W., and Rubin, D. B. (1997), “Bayesian Inference for Causal Effects in Randomized Experiments with Noncompliance,” Annals of Statistics, 25, 305–327.
26. Kaiser Family Foundation (2000), “The State of the HIV/AIDS Epidemic in America,” Capitol Hill Briefing Series on HIV/AIDS.
27. Lam, N. S. N., and Liu, K. B. (1998), “Use of Space-Filling Curves in Generating a National Rural Sampling Frame for HIV/AIDS Research,” Professional Geographer, 48, 321–332.
28. Lancaster, T., and Intrator, O. (1998), “Panel Data with Survival: Hospitalization of HIV-Positive Patients,” Journal of the American Statistical Association, 93, 46–53.
29. McClellan, M., McNeil, B., and Newhouse, J. P. (1994), “Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality? Analysis Using Instrumental Variables,” Journal of the American Medical Association, 272, 859–866.
30. Nelson, C. R., and Startz, R. (1990), “Some Further Results on the Exact Small Sample Properties of the Instrumental Variable Estimator,” Econometrica, 58, 967–976.
31. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, J. F., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998), “Declining Morbidity and Mortality Among Patients With Advanced Human Immunodeficiency Virus Infection: HIV Outpatient Study Investigators,” New England Journal of Medicine 338, 853–860.
32. Quandt, R. (1972), “A New Approach to Estimating Switching Regressions,” Journal of the American Statistical Association, 67, 306–310.
33. Rao, J. N. K., and Scott, A. J. (1981), “The Analysis of Categorical Data from Complex Sample Surveys: Chi-Squared Tests for Goodness-of-Fit and Independence in Two-Way Tables,” Journal of the American Medical Association, 76, 221–230.
34. Roy, A. D. (1951), “Some Thoughts on the Distribution of Earnings,” Oxford Economic Papers (New Series), 3, 135–146.
35. Rubin, D. B. (1978), “Bayesian Inference for Causal Effects: The Role of Randomization,” Annals of Statistics, 7, 34–58.
36. Rubin, D. B. (1991), “Practical Implications of Modes of Statistical Inference for Causal Effects and the Critical Role of the Assignment Mechanism,” Biometrics, 47, 1213–1234.
37. Shapiro, M. F., Berk, M. L., Berry, S. H., Emmons, C., Athey, L. A., Hsia, D. C., Leibowitz, A. A., Maida, C. A., Marcus, M., Perlman, J. F., Schur, C. L., Schuster, M. A., Senterfitt, W. A., and Bozzette, S. A. (1999a), “National Probability Samples in Studies of Low-Prevalence Diseases, Part 1: Perspectives and Lessons Learned from the HIV Cost and Services Utilization Study,” Health Services Research, 34, 969–992.
38. Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Andersen, R. M., Berk, M. L., Bing, E. G., Cleary, P. D., Cunningham, W. E., Fleishman, J. A., Kanouse, D. E., Senterfitt, J. W., and Bozzette, S. A. (1999b), “Variations in the Care of HIV-Infected Adults in the United States. Results From the HIV Cost and Services Utilization Study,” Journal of the American Medical Association, 281, 2305–2315.
39. Skinner, C. J. (1989), “Introduction to Part A” in Analysis of Complex Surveys, C. J. Skinner, D. Holt, and T. M. F. Smith (eds.), New York: Wiley.
40. Staiger, D., and Stock, J. H. (1997), “Instrumental Variables Regression with Weak Instruments,” Econometrica, 65, 557–586.
41. United States General Accounting Office (1998), “HIV/AIDS Drugs: Funding Implications of New Combination Therapies for Federal and State Programs,” Report GAO-HEHS-99-2.